Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Investor Claims in Class Action

Rosen Law Firm Investigates Possible Securities Claims



The Rosen Law Firm, a recognized advocate for investor rights, is currently looking into potential securities claims that may affect shareholders of Disc Medicine, Inc. (NASDAQ: IRON). This investigation stems from allegations that the company might have issued significant misleading business information to the public, which has serious implications for investors.

Why the Investigation Matters



On February 13, 2026, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) concerning Disc Medicine’s new drug application (NDA) for its bitopertin program, which is crucial for the company's future prospects. The FDA’s letter indicated that the NDA could not be approved due to existing uncertainties and the necessity for additional evidence. As a result of this unsettling news, Disc Medicine’s stock price experienced a dramatic fall of 22% on the day the announcement was made.

This sudden decline has raised red flags among investors, urging them to seek clarification and possibly compensation. The Rosen Law Firm is preparing a class action aimed at recovering losses for those who purchased Disc Medicine shares within the relevant timeframe.

What Investors Should Do



For individuals who have invested in Disc Medicine securities, taking action may be essential. The Rosen Law Firm is accepting inquiries about joining the class action without requiring any payment upfront due to a contingency fee agreement. Those interested can easily access the firm’s submission portal at rosenlegal.com or reach out by calling Phillip Kim, Esq. toll-free at 866-767-3653 or email at [email protected].

Importance of Qualified Legal Representation



When selecting legal counsel during such critical times, it is imperative to choose an experienced firm with a successful track record in handling securities class actions. Many legal notices you may come across might not be backed by adequate experience or resources. The Rosen Law Firm has proven success in this arena, having previously secured the largest securities class action settlement against a Chinese company and being consistently ranked in the top tiers of law firms representing investors.

Achievements of Rosen Law Firm



Notably, in 2017, the firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements achieved and has earned recognition for securing hundreds of millions of dollars in recoveries for investors. Just in 2019, they successfully obtained over $438 million for their clients, showcasing their capability to fight for investor rights actively.

The founder, Laurence Rosen, has been acknowledged as a Titan of the Plaintiffs' Bar by Law360, further affirming the firm’s industry stature. Many attorneys at the firm also hold honors from organizations such as Lawdragon and Super Lawyers.

Staying Informed



To remain updated on this ongoing situation and receive related news, investors can follow The Rosen Law Firm on social media platforms including LinkedIn, Twitter, and Facebook.

Contact Details for Further Assistance
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll-Free: 866-767-3653
Fax: (212) 202-3827
Email: [email protected]
Website: www.rosenlegal.com

As a reminder, this communication serves as attorney advertising. Outcomes from previous cases may not predict future results, so investors are urged to act promptly and consult with legal professionals for their specific situations.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.